NOBUO TSUCHIDA, MASA-AKI IKEDA,
YOSHIZUMU ISHINO, MICHELE GRIECO and GIANCARLO VECCHIO
Int J Oncol 50:[Related
article:] 2043–2048, 2017
Subsequent to the publication of the above paper, the
authors noted that: 1) there was an error on Fig. 4, page 2046, in which the symbols of
α-L-fucosidase 1 (FUCA1) and fucosyltransferase 8 (FUT8) had been
mistakenly labelled the wrong way around (FUCA1 should have been
represented by the blue bars, and FUT8 by the red), and 2) the
sentence 'Average levels of FUCA1 mRNA were low in ATCs
while expression levels in PTC samples were comparable or slightly
higher than those present in normal thyroid tissues (Fig. 4)', page 2046, left column, 4th line
from the bottom, was not appropriate to explain the result of
Fig. 4. Therefore, this sentence
is replaced by: 'FUCA1 RNA expression levels were found to
be lower in anaplastic thyroid cancer samples (ATCs), while they
were higher in papillary thyroid cancer samples (PTCs) and in
normal thyroid tissues (Fig.
4)'.
 | Figure 4Microarray analyses of FUT8
(red) and FUCA1 (blue) expression. Four ATC samples (T11,
T12, T14, T17), 8 PTC samples (T1, T2, T3, T4, T5, T6, T9, T10),
and 4 normal thyroid tissues (NT1, NT2, NT3, NT4) are shown. |
The corrected version of Fig. 4 is shown below, which now
accurately shows how FUCA1 RNA expression levels were found
to be lower in anaplastic thyroid cancer samples (ATCs), while they
were higher in papillary thyroid cancer samples (PTCs) and in
normal thyroid tissues. We sincerely apologize for the mistake and
the inappropriate explanation in the text, and thank the reader of
our article who drew this matter to our attention. Furthermore, we
regret any inconvenience these chages have caused.
